Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 457Recruiting 147Terminated 112Unknown 94Active not recruiting 56Withdrawn 32Not yet recruiting 25Enrolling by invitation 5Suspended 2No longer available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 27Carcinoma, Renal Cell 11Melanoma 4Colorectal Neoplasms 4Urinary Bladder Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Kidney Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Radiation Injuries 1Prostatic Hyperplasia 1Penile Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Nocturia 1Nephrolithiasis, Calcium Oxalate 1Multiple Myeloma 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1

Interventions

N-acetylcochinol-O-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Kidney Neoplasms × Genitourinary × Clear all
NCT05210933 2026-04-13

SMART

University of Alberta

Suspended
750 enrolled
Genitourinary

Kidney Neoplasms

NCT00065572 2011-01-26

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

AstraZeneca

Phase 2 Suspended
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡